5min chapter

Bloomberg Talks cover image

Merck CEO Rob Davis Talks Winrevair Approval

Bloomberg Talks

CHAPTER

Merck's FDA Approval and Strategic Portfolio Diversification

An in-depth look at Merck's groundbreaking FDA approval of Winrever, a novel drug for pulmonary arterial hypertension, and the strategic importance of portfolio diversification in addressing underlying diseases like fatty liver.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode